| regulation of endocytic recycling | GO:2001135 | 3 | 1.000 | |
| positive regulation of endocytic recycling | GO:2001137 | 2 | 0.999 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.993 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.989 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.978 | |
| nephron development | GO:0072006 | 109 | 0.971 | |
| positive regulation of syncytium formation by plasma membrane fusion | GO:0060143 | 17 | 0.960 | |
| urogenital system development | GO:0001655 | 261 | 0.937 | |
| myotube differentiation | GO:0014902 | 105 | 0.936 | |
| kidney development | GO:0001822 | 213 | 0.934 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.918 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.905 | |
| metanephric glomerular mesangial cell proliferation involved in metanephros development | GO:0072262 | 3 | 0.898 | |
| establishment of protein localization to plasma membrane | GO:0090002 | 34 | 0.893 | |
| renal system process | GO:0003014 | 48 | 0.875 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.874 | |
| regulation of renal output by angiotensin | GO:0002019 | 2 | 0.869 | |
| cholesterol storage | GO:0010878 | 4 | 0.857 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.836 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.828 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.810 | |
| t cell activation | GO:0042110 | 289 | 0.798 | |
| germ cell development | GO:0007281 | 185 | 0.779 | |
| sperm individualization | GO:0007291 | 1 | 0.776 | |
| renal tubule development | GO:0061326 | 87 | 0.768 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.763 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.758 | |
| renin angiotensin regulation of aldosterone production | GO:0002018 | 3 | 0.754 | |
| ovulation | GO:0030728 | 15 | 0.752 | |
| extracellular structure organization | GO:0043062 | 148 | 0.745 | |
| inflammatory response | GO:0006954 | 244 | 0.744 | |
| spermatogenesis | GO:0007283 | 284 | 0.729 | |
| intracellular protein transport | GO:0006886 | 204 | 0.724 | |
| vascular endothelial growth factor signaling pathway | GO:0038084 | 10 | 0.720 | |
| syncytium formation | GO:0006949 | 43 | 0.715 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.713 | |
| response to growth factor | GO:0070848 | 198 | 0.711 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.704 | |
| female gamete generation | GO:0007292 | 74 | 0.703 | |
| organelle assembly | GO:0070925 | 177 | 0.698 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.696 | |
| intrinsic apoptotic signaling pathway by p53 class mediator | GO:0072332 | 35 | 0.687 | |
| nephron tubule development | GO:0072080 | 84 | 0.674 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.672 | |
| regulation of transcription from rna polymerase ii promoter in response to hypoxia | GO:0061418 | 2 | 0.665 | |
| positive regulation of necrotic cell death | GO:0010940 | 1 | 0.660 | |
| positive regulation of myotube differentiation | GO:0010831 | 24 | 0.656 | |
| positive regulation of protein localization to plasma membrane | GO:1903078 | 7 | 0.655 | |
| activation of janus kinase activity | GO:0042976 | 2 | 0.651 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.645 | |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.640 | |
| membrane organization | GO:0061024 | 245 | 0.632 | |
| glomerulus development | GO:0032835 | 40 | 0.632 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.624 | |
| regulation of syncytium formation by plasma membrane fusion | GO:0060142 | 23 | 0.623 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.619 | |
| spermatid differentiation | GO:0048515 | 115 | 0.618 | |
| actin filament organization | GO:0007015 | 113 | 0.617 | |
| regulation of ion transport | GO:0043269 | 215 | 0.616 | |
| endocytosis | GO:0006897 | 168 | 0.614 | |
| protein targeting to membrane | GO:0006612 | 20 | 0.614 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.606 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.604 | |
| positive regulation of muscle cell differentiation | GO:0051149 | 39 | 0.594 | |
| metanephric glomerular endothelium development | GO:0072264 | 1 | 0.593 | |
| nuclear division | GO:0000280 | 158 | 0.593 | |
| positive regulation of p38mapk cascade | GO:1900745 | 1 | 0.590 | |
| negative regulation of intrinsic apoptotic signaling pathway | GO:2001243 | 34 | 0.579 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.578 | |
| response to vitamin d | GO:0033280 | 3 | 0.572 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.572 | |
| spermatid development | GO:0007286 | 108 | 0.570 | |
| cation transport | GO:0006812 | 399 | 0.564 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.558 | |
| leukocyte migration | GO:0050900 | 124 | 0.554 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.552 | |
| regulation of myeloid dendritic cell activation | GO:0030885 | 5 | 0.547 | |
| development of primary sexual characteristics | GO:0045137 | 143 | 0.547 | |
| protein localization to plasma membrane | GO:0072659 | 57 | 0.545 | |
| regulation of necrotic cell death | GO:0010939 | 13 | 0.542 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.539 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.534 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.527 | |
| male gamete generation | GO:0048232 | 285 | 0.523 | |
| organelle fission | GO:0048285 | 170 | 0.517 | |
| positive regulation of striated muscle cell differentiation | GO:0051155 | 35 | 0.516 | |
| cellularization | GO:0007349 | 1 | 0.514 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.512 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.509 | |
| kidney epithelium development | GO:0072073 | 121 | 0.505 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.505 | |
| cellular response to insulin stimulus | GO:0032869 | 78 | 0.501 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.496 | |
| calcium ion transport | GO:0006816 | 159 | 0.496 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.492 | |
| negative regulation of anoikis | GO:2000811 | 2 | 0.491 | |
| regulation of angiotensin metabolic process | GO:0060177 | 4 | 0.491 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 0.483 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.482 | |
| vegf activated neuropilin signaling pathway | GO:0038190 | 2 | 0.479 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.470 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.469 | |
| response to osmotic stress | GO:0006970 | 21 | 0.468 | |
| blood circulation | GO:0008015 | 195 | 0.465 | |
| cellular response to peptide | GO:1901653 | 92 | 0.463 | |
| nucleoside monophosphate metabolic process | GO:0009123 | 85 | 0.454 | |
| ear development | GO:0043583 | 200 | 0.450 | |
| smooth muscle cell migration | GO:0014909 | 10 | 0.448 | |
| protein targeting to plasma membrane | GO:0072661 | 7 | 0.446 | |
| g protein coupled receptor signaling pathway | GO:0007186 | 243 | 0.441 | |
| protein o linked glycosylation | GO:0006493 | 16 | 0.437 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.433 | |
| regulation of protein localization | GO:0032880 | 231 | 0.433 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.431 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.429 | |
| response to corticosterone | GO:0051412 | 1 | 0.428 | |
| striated muscle myosin thick filament assembly | GO:0071688 | 1 | 0.425 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.423 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.421 | |
| ureteric bud development | GO:0001657 | 94 | 0.421 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.420 | |
| regulation of cell migration | GO:0030334 | 219 | 0.419 | |
| cilium morphogenesis | GO:0060271 | 102 | 0.415 | |
| branching involved in ureteric bud morphogenesis | GO:0001658 | 56 | 0.409 | |
| cell adhesion | GO:0007155 | 329 | 0.405 | |
| protein localization to organelle | GO:0033365 | 185 | 0.401 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.399 | |
| regulation of intrinsic apoptotic signaling pathway by p53 class mediator | GO:1902253 | 13 | 0.394 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.394 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.393 | |
| renal filtration cell differentiation | GO:0061318 | 10 | 0.390 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.387 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.381 | |
| regulation of dna templated transcription in response to stress | GO:0043620 | 9 | 0.379 | |
| response to amino acid | GO:0043200 | 37 | 0.378 | |
| muscle tissue development | GO:0060537 | 308 | 0.378 | |
| response to alcohol | GO:0097305 | 48 | 0.377 | |
| pronephric nephron development | GO:0039019 | 1 | 0.374 | |
| p38mapk cascade | GO:0038066 | 4 | 0.371 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.367 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.364 | |
| regulation of angiotensin levels in blood | GO:0002002 | 4 | 0.364 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.361 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.360 | |
| plasma membrane organization | GO:0007009 | 90 | 0.359 | |
| regulation of systemic arterial blood pressure by circulatory renin angiotensin | GO:0001991 | 13 | 0.359 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.358 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.350 | |
| mitochondrial dna replication | GO:0006264 | 7 | 0.350 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.349 | |
| muscle system process | GO:0003012 | 141 | 0.349 | |
| jak stat cascade | GO:0007259 | 42 | 0.348 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.346 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.345 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.343 | |
| response to insulin | GO:0032868 | 100 | 0.341 | |
| cell growth involved in cardiac muscle cell development | GO:0061049 | 3 | 0.334 | |
| mitochondrion organization | GO:0007005 | 134 | 0.332 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.328 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.326 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.325 | |
| muscle cell development | GO:0055001 | 133 | 0.325 | |
| positive regulation of establishment of protein localization to plasma membrane | GO:0090004 | 7 | 0.323 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.320 | |
| nuclear transport | GO:0051169 | 139 | 0.319 | |
| kidney vasculature development | GO:0061440 | 15 | 0.318 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902238 | 1 | 0.317 | |
| regulation of metanephros development | GO:0072215 | 15 | 0.316 | |
| regulation of glomerulus development | GO:0090192 | 6 | 0.315 | |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.313 | |
| protein targeting | GO:0006605 | 143 | 0.312 | |
| protein localization to endosome | GO:0036010 | 2 | 0.311 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.309 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.309 | |
| positive regulation of intracellular transport | GO:0032388 | 70 | 0.308 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.304 | |
| response to peptide hormone | GO:0043434 | 127 | 0.303 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.300 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.300 | |
| positive regulation of mitotic cell cycle embryonic | GO:0045977 | 2 | 0.300 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.299 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.296 | |
| lipid homeostasis | GO:0055088 | 63 | 0.295 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.293 | |
| deoxyribonucleotide biosynthetic process | GO:0009263 | 6 | 0.293 | |
| muscle contraction | GO:0006936 | 101 | 0.293 | |
| metanephros development | GO:0001656 | 79 | 0.291 | |
| renal system development | GO:0072001 | 225 | 0.288 | |
| metanephric glomerulus vasculature development | GO:0072239 | 7 | 0.287 | |
| metanephric mesangial cell differentiation | GO:0072209 | 1 | 0.287 | |
| respiratory system development | GO:0060541 | 190 | 0.285 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.284 | |
| gliogenesis | GO:0042063 | 141 | 0.282 | |
| regulation of striated muscle cell differentiation | GO:0051153 | 81 | 0.279 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.278 | |
| necrotic cell death | GO:0070265 | 30 | 0.275 | |
| amine metabolic process | GO:0009308 | 45 | 0.275 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.275 | |
| cellular response to peptide hormone stimulus | GO:0071375 | 92 | 0.273 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.272 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.271 | |
| angiogenesis | GO:0001525 | 201 | 0.270 | |
| regulation of endothelial cell chemotaxis | GO:2001026 | 1 | 0.269 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.266 | |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.265 | |
| negative regulation of endoplasmic reticulum calcium ion concentration | GO:0032471 | 3 | 0.264 | |
| hindbrain radial glia guided cell migration | GO:0021932 | 12 | 0.263 | |
| multicellular organismal homeostasis | GO:0048871 | 164 | 0.263 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.261 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.261 | |
| gonad development | GO:0008406 | 141 | 0.259 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.258 | |
| cholesterol homeostasis | GO:0042632 | 44 | 0.253 | |
| oogenesis | GO:0048477 | 56 | 0.251 | |
| sterol homeostasis | GO:0055092 | 45 | 0.247 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.246 | |
| cell substrate junction assembly | GO:0007044 | 24 | 0.246 | |
| negative regulation of heart rate | GO:0010459 | 4 | 0.246 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.245 | |
| positive regulation of blood pressure | GO:0045777 | 21 | 0.245 | |
| glomerular epithelium development | GO:0072010 | 11 | 0.244 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.243 | |
| protein maturation | GO:0051604 | 176 | 0.241 | |
| mesangial cell differentiation | GO:0072007 | 4 | 0.241 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.240 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.239 | |
| nephron epithelium development | GO:0072009 | 92 | 0.239 | |
| camera type eye development | GO:0043010 | 266 | 0.237 | |
| neuropilin signaling pathway | GO:0038189 | 2 | 0.236 | |
| regulation of cell migration involved in sprouting angiogenesis | GO:0090049 | 4 | 0.235 | |
| regulation of neuron death | GO:1901214 | 134 | 0.235 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.234 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.232 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.232 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.232 | |
| vesicle organization | GO:0016050 | 60 | 0.230 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.228 | |
| connective tissue development | GO:0061448 | 179 | 0.227 | |
| positive regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903378 | 3 | 0.225 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.225 | |
| negative regulation of systemic arterial blood pressure | GO:0003085 | 15 | 0.225 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.225 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.223 | |
| lymphocyte migration | GO:0072676 | 26 | 0.223 | |
| positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation | GO:2000721 | 2 | 0.222 | |
| regulation of cell motility | GO:2000145 | 236 | 0.221 | |
| glial cell apoptotic process | GO:0034349 | 3 | 0.220 | |
| rhythmic process | GO:0048511 | 174 | 0.219 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.218 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.218 | |
| immune effector process | GO:0002252 | 321 | 0.216 | |
| regulation of pigment cell differentiation | GO:0050932 | 7 | 0.215 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.214 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 11 | 0.214 | |
| positive regulation of protein autophosphorylation | GO:0031954 | 4 | 0.212 | |
| deoxyribonucleoside triphosphate metabolic process | GO:0009200 | 9 | 0.212 | |
| negative regulation of kinase activity | GO:0033673 | 81 | 0.210 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.210 | |
| adrenal cortex formation | GO:0035802 | 2 | 0.209 | |
| metanephric s shaped body morphogenesis | GO:0072284 | 2 | 0.208 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.207 | |
| axon guidance | GO:0007411 | 141 | 0.207 | |
| regulation of ph | GO:0006885 | 26 | 0.206 | |
| regulation of cell activation | GO:0050865 | 289 | 0.205 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.205 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.204 | |
| negative regulation of rho protein signal transduction | GO:0035024 | 7 | 0.204 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.203 | |
| positive regulation of endothelial cell chemotaxis | GO:2001028 | 1 | 0.202 | |
| negative regulation of intracellular signal transduction | GO:1902532 | 167 | 0.200 | |
| purine nucleoside monophosphate catabolic process | GO:0009128 | 58 | 0.200 | |
| dendritic spine maintenance | GO:0097062 | 4 | 0.199 | |
| protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | GO:0001844 | 4 | 0.199 | |
| axonogenesis | GO:0007409 | 274 | 0.196 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.194 | |
| establishment of protein localization to membrane | GO:0090150 | 54 | 0.194 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.193 | |
| t cell differentiation | GO:0030217 | 174 | 0.193 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.193 | |
| hindbrain development | GO:0030902 | 128 | 0.193 | |
| endomembrane system organization | GO:0010256 | 147 | 0.193 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.193 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.191 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.189 | |
| induction of positive chemotaxis | GO:0050930 | 7 | 0.188 | |
| positive regulation of smooth muscle contraction | GO:0045987 | 7 | 0.188 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.187 | |
| positive regulation of reactive oxygen species biosynthetic process | GO:1903428 | 2 | 0.187 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.187 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.187 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.186 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.186 | |
| extrinsic apoptotic signaling pathway in absence of ligand | GO:0097192 | 55 | 0.185 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.184 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.184 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.183 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.183 | |
| heart process | GO:0003015 | 94 | 0.182 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.179 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.176 | |
| substrate dependent cell migration cell extension | GO:0006930 | 4 | 0.175 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.175 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.175 | |
| postganglionic parasympathetic nervous system development | GO:0021784 | 2 | 0.174 | |
| cerebral cortex cell migration | GO:0021795 | 44 | 0.172 | |
| regulation of phospholipase c activity | GO:1900274 | 3 | 0.172 | |
| retina morphogenesis in camera type eye | GO:0060042 | 45 | 0.172 | |
| erythropoietin mediated signaling pathway | GO:0038162 | 1 | 0.171 | |
| regulation of intrinsic apoptotic signaling pathway in response to osmotic stress | GO:1902218 | 1 | 0.170 | |
| substrate adhesion dependent cell spreading | GO:0034446 | 30 | 0.170 | |
| regulation of metanephric glomerulus development | GO:0072298 | 5 | 0.170 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.170 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.170 | |
| renal system process involved in regulation of systemic arterial blood pressure | GO:0003071 | 15 | 0.169 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.168 | |
| phospholipase c activating g protein coupled receptor signaling pathway | GO:0007200 | 26 | 0.168 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.168 | |
| regulation of protein targeting | GO:1903533 | 61 | 0.167 | |
| adrenergic receptor signaling pathway | GO:0071875 | 13 | 0.166 | |
| muscle cell migration | GO:0014812 | 19 | 0.166 | |
| protein localization to membrane | GO:0072657 | 108 | 0.166 | |
| vasoconstriction | GO:0042310 | 27 | 0.166 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.166 | |
| positive regulation of protein targeting to membrane | GO:0090314 | 7 | 0.165 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.164 | |
| digestive tract development | GO:0048565 | 190 | 0.164 | Mouse |
| negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1902239 | 1 | 0.164 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.162 | |
| negative regulation of myeloid dendritic cell activation | GO:0030886 | 3 | 0.162 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.162 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.161 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.161 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.161 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.159 | |
| neuron projection guidance | GO:0097485 | 141 | 0.159 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.158 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.158 | |
| rhombomere 5 formation | GO:0021666 | 1 | 0.158 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.157 | |
| photoreceptor cell differentiation | GO:0046530 | 52 | 0.157 | |
| s shaped body morphogenesis | GO:0072050 | 6 | 0.156 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.155 | |
| nerve development | GO:0021675 | 67 | 0.155 | |
| chemotaxis | GO:0006935 | 247 | 0.155 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.155 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.154 | |
| hair cycle | GO:0042633 | 90 | 0.153 | |
| response to organophosphorus | GO:0046683 | 22 | 0.152 | |
| lung development | GO:0030324 | 164 | 0.151 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.150 | |
| regulation of wound healing | GO:0061041 | 40 | 0.150 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.149 | |
| regulation of activation of jak2 kinase activity | GO:0010534 | 1 | 0.149 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.149 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.148 | |
| renal tubule morphogenesis | GO:0061333 | 72 | 0.147 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c | GO:0008635 | 4 | 0.145 | |
| ceramide metabolic process | GO:0006672 | 31 | 0.145 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.144 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.143 | |
| gtp metabolic process | GO:0046039 | 144 | 0.143 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.143 | |
| positive regulation of muscle contraction | GO:0045933 | 10 | 0.142 | |
| sprouting angiogenesis | GO:0002040 | 26 | 0.141 | |
| smooth muscle contraction | GO:0006939 | 44 | 0.141 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.141 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.138 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.138 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.137 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.136 | |
| mitochondrial outer membrane permeabilization | GO:0097345 | 10 | 0.136 | |
| metanephric glomerulus development | GO:0072224 | 13 | 0.135 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.135 | |
| membrane lipid metabolic process | GO:0006643 | 53 | 0.135 | |
| regulation of heart contraction | GO:0008016 | 77 | 0.134 | |
| response to oxygen levels | GO:0070482 | 62 | 0.134 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.133 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.133 | |
| cell chemotaxis | GO:0060326 | 81 | 0.133 | |
| negative regulation of neurotransmitter transport | GO:0051589 | 7 | 0.133 | |
| cytokine production | GO:0001816 | 319 | 0.132 | |
| myosin filament organization | GO:0031033 | 3 | 0.132 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.131 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator | GO:1990127 | 1 | 0.131 | |
| heart contraction | GO:0060047 | 93 | 0.131 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.131 | |
| dna repair | GO:0006281 | 107 | 0.131 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001269 | 3 | 0.130 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.129 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.129 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.128 | |
| regulation of glomerular mesangial cell proliferation | GO:0072124 | 1 | 0.127 | |
| regulation of branching involved in salivary gland morphogenesis by epithelial mesenchymal signaling | GO:0060683 | 1 | 0.127 | |
| post embryonic camera type eye development | GO:0031077 | 8 | 0.126 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.124 | |
| response to peptide | GO:1901652 | 136 | 0.124 | |
| metanephric epithelium development | GO:0072207 | 21 | 0.124 | |
| mitochondrial genome maintenance | GO:0000002 | 15 | 0.124 | |
| regulation of glomerular filtration | GO:0003093 | 3 | 0.123 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.123 | |
| angiogenesis involved in coronary vascular morphogenesis | GO:0060978 | 2 | 0.123 | |
| atp metabolic process | GO:0046034 | 75 | 0.123 | |
| positive regulation of b cell apoptotic process | GO:0002904 | 4 | 0.123 | |
| embryonic viscerocranium morphogenesis | GO:0048703 | 8 | 0.118 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.118 | |
| renal system process involved in regulation of blood volume | GO:0001977 | 4 | 0.117 | |
| angiotensin activated signaling pathway | GO:0038166 | 4 | 0.117 | |
| substrate dependent cell migration | GO:0006929 | 18 | 0.117 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.117 | |
| negative regulation of metanephric glomerulus development | GO:0072299 | 1 | 0.117 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.117 | |
| cerebral cortex radial glia guided migration | GO:0021801 | 17 | 0.116 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.116 | |
| regulation of neurotrophin trk receptor signaling pathway | GO:0051386 | 4 | 0.115 | |
| regulation of tube size | GO:0035150 | 57 | 0.115 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.114 | |
| response to radiation | GO:0009314 | 165 | 0.114 | |
| b cell activation | GO:0042113 | 161 | 0.114 | |
| ribonucleoside monophosphate catabolic process | GO:0009158 | 57 | 0.114 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.113 | |
| intrinsic apoptotic signaling pathway in response to osmotic stress | GO:0008627 | 2 | 0.113 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.113 | |
| gamma delta t cell differentiation | GO:0042492 | 11 | 0.112 | |
| regulation of systemic arterial blood pressure by hormone | GO:0001990 | 25 | 0.112 | |
| negative regulation of ras protein signal transduction | GO:0046580 | 18 | 0.112 | |
| apoptotic process involved in embryonic digit morphogenesis | GO:1902263 | 3 | 0.111 | |
| protein processing | GO:0016485 | 163 | 0.110 | |
| morphogenesis of a polarized epithelium | GO:0001738 | 37 | 0.110 | |
| striated muscle cell development | GO:0055002 | 125 | 0.110 | |
| response to fructose | GO:0009750 | 2 | 0.110 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.110 | |
| cardiac muscle fiber development | GO:0048739 | 4 | 0.109 | |
| regulation of lymphangiogenesis | GO:1901490 | 3 | 0.108 | |
| myosin filament assembly | GO:0031034 | 2 | 0.108 | |
| positive regulation of bmp signaling pathway | GO:0030513 | 23 | 0.107 | Mouse |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.107 | |
| metanephric part of ureteric bud development | GO:0035502 | 2 | 0.106 | |
| cerebellar cortex morphogenesis | GO:0021696 | 32 | 0.106 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.105 | |
| cerebellum development | GO:0021549 | 77 | 0.104 | |
| blood coagulation | GO:0007596 | 76 | 0.104 | |
| regulation of protein transport | GO:0051223 | 163 | 0.104 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.104 | |
| regulation of norepinephrine secretion | GO:0014061 | 2 | 0.103 | |
| microglia differentiation | GO:0014004 | 2 | 0.103 | |
| mesoderm development | GO:0007498 | 100 | 0.102 | Mouse |
| adherens junction assembly | GO:0034333 | 22 | 0.101 | |
| carbohydrate transport | GO:0008643 | 62 | 0.101 | |
| response to iron ion | GO:0010039 | 4 | 0.101 | |
| regulation of cellular response to growth factor stimulus | GO:0090287 | 82 | 0.101 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.100 | |
| regulation of osteoblast proliferation | GO:0033688 | 15 | 0.100 | |
| cell junction organization | GO:0034330 | 77 | 0.099 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.099 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.098 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.098 | |
| protein import into nucleus | GO:0006606 | 95 | 0.098 | |
| mesonephros development | GO:0001823 | 97 | 0.097 | |
| positive regulation of phosphatase activity | GO:0010922 | 4 | 0.096 | |
| cellular response to acid chemical | GO:0071229 | 68 | 0.096 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.096 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.095 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.095 | |
| rna splicing | GO:0008380 | 54 | 0.095 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.095 | |
| dna metabolic process | GO:0006259 | 303 | 0.095 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.094 | |
| striated muscle contraction | GO:0006941 | 45 | 0.094 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.094 | |
| response to macrophage colony stimulating factor | GO:0036005 | 3 | 0.093 | |
| positive regulation of protein transport | GO:0051222 | 93 | 0.093 | |
| response to monosaccharide | GO:0034284 | 67 | 0.093 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.093 | |
| sensory perception | GO:0007600 | 245 | 0.093 | |
| positive regulation of proteolysis involved in cellular protein catabolic process | GO:1903052 | 31 | 0.093 | |
| response to ketone | GO:1901654 | 15 | 0.093 | |
| oxidation reduction process | GO:0055114 | 342 | 0.093 | |
| cardiac muscle tissue morphogenesis | GO:0055008 | 44 | 0.093 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.092 | |
| labyrinthine layer morphogenesis | GO:0060713 | 21 | 0.092 | |
| cerebellum morphogenesis | GO:0021587 | 42 | 0.091 | |
| regulation of axon extension | GO:0030516 | 43 | 0.091 | |
